TrialBritish journal of haematology2020
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia.
Ralph Boccia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this paperpooled itcites it